STEVENS CAPITAL MANAGEMENT LP - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 143 filers reported holding INFINITY PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.80 and the average weighting 0.1%.

Quarter-by-quarter ownership
STEVENS CAPITAL MANAGEMENT LP ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2016$90,000
-3.2%
17,082
+44.5%
0.00%0.0%
Q4 2015$93,000
-64.5%
11,819
-61.9%
0.00%
-66.7%
Q3 2015$262,000
+43.2%
31,039
+85.2%
0.01%
+71.4%
Q2 2015$183,000
-47.1%
16,756
-18.3%
0.01%
-41.7%
Q4 2014$346,000
+109.7%
20,502
+48.1%
0.01%
+200.0%
Q1 2014$165,000
-34.8%
13,841
-24.5%
0.00%
-42.9%
Q4 2013$253,00018,3440.01%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q1 2015
NameSharesValueWeighting ↓
BVF INC/IL 15,232,268$29,094,0002.84%
EcoR1 Capital, LLC 412,000$787,0000.08%
PLATINUM INVESTMENT MANAGEMENT LTD 1,130,432$2,159,0000.05%
ESSEX INVESTMENT MANAGEMENT CO LLC 164,605$314,0000.04%
Clear Harbor Asset Management, LLC 95,630$183,0000.03%
ALGERT GLOBAL LLC 72,556$139,0000.03%
180 WEALTH ADVISORS, LLC 30,000$57,0000.03%
GSA CAPITAL PARTNERS LLP 289,854$554,0000.03%
PRELUDE CAPITAL MANAGEMENT, LLC 85,412$163,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 459,000$877,0000.01%
View complete list of INFINITY PHARMACEUTICALS INC shareholders